Displaying 1941 - 1960 of 2297
New Mexico Court Temporarily Blocks Western Refinings Acquisition of Rival Energy Company Giant Industries, Inc.
Date
At the request of the Federal Trade Commission, the U.S. District Court for the District of New Mexico has issued a temporary restraining order (TRO) blocking Western Refining, Inc.’s proposed $1.4...
Apr10
Energy Markets in the 21st Century: Competition Policy in Perspective
-
The FTC hosted a conference to explore a range of energy issues of importance to American consumers and the U.S. and global economies. The conference brought together leading experts from the...
FTC Seeks to Block Western Refinings Proposed Acquisition of Giant Industries
Date
The Federal Trade Commission today approved a complaint challenging Western Refining, Inc.’s (Western) approximately $1.4 billion acquisition of rival energy company Giant Industries, Inc. (Giant) and...
FTC Issues FY 2006 FDCPA Report to Congress; Commission Approves Filing of Amended Complaint in Matter of Global Marketing Group, Inc.; FTC Approves Federal Register Notice on Recycled Oil Rule; FTC Approves Federal Register Notice on Agency Systems of
Date
Commission approval of reports to Congress: The Commission has authorized the staff to release publicly the 29th Annual Report to Congress on the Fair Debt Collection Practices Act (FDCPA). This...
FTC Sues to Block Acquisition of The Peoples Natural Gas Company from Dominion Resources
Date
Transaction Would Result in Merger to Monopoly in Southwestern Pennsylvania The Federal Trade Commission has approved a complaint challenging Equitable Resources, Inc.’s (Equitable) proposed...
Missouri Funeral Regulators Agree to Settle FTC Antitrust Charges
Date
Will Not Adopt Rules to Block Retail Casket Sales Missouri funeral regulators have agreed to settle antitrust charges by the Federal Trade Commission, affirming that they will not prohibit or...
FTC Provides U.S. Senate with Overview of Recent Antitrust Activities
Date
Agency Has Focused Enforcement on Sectors of Economy with Greatest Impact on Consumers Providing Federal Trade Commission testimony today before the U.S. Senate Judiciary Committee’s Subcommittee on...
FTC Testifies on Patent Reform Recommendations
Date
The Federal Trade Commission told a subcommittee of the House Judiciary Committee today that patent policy stimulates innovation by providing an incentive to develop and commercialize inventions, but...
Feb13
Broadband Connectivity Competition Policy
-
The FTC hosted a public workshop on that brought together experts from business, government, and the technology sector, consumer advocates, and academics to explore competition and consumer protection...
MiRealSource Settles Charges it Illegally Restrained Competition
Date
The Federal Trade Commission today announced that it has settled charges brought against a group of real estate brokers in southeastern Michigan for violating the antitrust laws by adopting and...
FTC Challenges Acquisition of Interests in Kinder Morgan, Inc. by The Carlyle Group and Riverstone Holdings
Date
To Protect Competition, Carlyle and Riverstone Must Make Their Investment in Magellan Midstream Holdings Passive and Restrict Flow of Sensitive Information The Federal Trade Commission today announced...
FTC Issues Updated Horizontal Merger Investigation Data Report
Date
Analyzes Transactions Occurring in Fiscal Years 1996-2005 The Federal Trade Commission today released its most recent staff analysis of horizontal merger investigations, describing transactions that...
FTC Challenges Hospira/Mayne Pharma Deal
Date
To Protect Competition, Companies Must Sell Assets for Five Generic Injectable Drugs The Federal Trade Commission today announced its challenge to Hospira Inc.’s (Hospira) proposed $2 billion...
FTC Provides Senate Testimony on Anticompetitive Patent Settlements in the U.S. Pharmaceutical Industry
Date
FTC Study Shows Substantial Increase in Number of Settlements Involving a Payment to the Generic and a Restriction on Generic Entry Testifying today on behalf of the Federal Trade Commission before...
Bureau of Competition Issues FY 2006 Summary of Pharmaceutical Company Settlement Agreements
Date
Shows Substantial Increase in the Number of Settlements Involving a Payment to the Generic and a Restriction on Generic Entry The Federal Trade Commission’s Bureau of Competition today issued a...
Watson Pharmaceuticals, Inc. and Andrx Corporation., In the Matter of
A consent order settled charges that Watson Pharmaceuticals, Inc.’s proposed $1.9 billion acquisition of Andrx Corporation, would have likely led to competitive problems in the markets for 13 generic drug products. Watson was required to end its marketing agreements with Interpham Holdings, divest Andrx’s right to develop, make, and market generic extended release tablets that correct the effects of type 2 diabetes, and divest Andrx’s rights and assets related to the developing and marketing of 11 generic oral contraceptives.
There is a related federal proceeding and two related administrative proceedings:
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0610139
Docket Number
C-4172
Displaying 1941 - 1960 of 2297